edema, but denied the existence of any other health problem except depression (untreated for the last few months). She was previously hospitalized for dyspnea. Her symptoms had been treated but her clinical picture had never been investigated. She did not have a family history of morbidity; the patient was not a smoker or alcohol consumer, and at the time was not using any medication. Systemic examination revealed intestinal constipation and palpitation. No family history of importance (including tuberculosis) was reported.
On physical examination, she had a regular general condition, hypocoloration, and eupnea. Her arterial pressure was 120/90 mmHg, pulse 90bpm, respiratory frequency 16rpm, and she had a 36.5 o C temperature. On segmental examination, she had engorged jugulars, crepitating stertors on pulmonary bases, hypophonetic yet rhythmic cardiac murmurs, slight lower limb edema, and slowed, deep tendinous reflexes.
Complementary examinations (performed on the first 3 days of hospitalization) showed, on thoracic radiography, a marked increase in the volume of the cardiac silhouette and slow right-side pleural effusion (Figure 1) , and on electrocardiography, sinus rhythm, low voltage on the frontal plane, and diffuse alteration of ventricle repolarization. The laboratory examination hemogram showed the following: hematocrit, 39.5%; hemoglobin, 13.2g/dL; mean corpuscle volume, 100 fL; leukocytes, 6,100 (5% rods); platelets, 311,000/ uL; urea, 39.6 mg/dL; creatinine, 0.78mg/dL; serum glucose, 78.5mg/dL; protrombin time, 13s; AST 81units/L; LDH, 791 units/L; CK, 1,438 units/L; VHS, 17s in 1h; nonreactive FAN; rheumatoid factor <20 (normal, nonreactive); VDRL, nonreactive. The partial urine was normal.
Echography showed bilateral pleural effusion, voluminous pericardial effusion, and the remaining structures were normal. An echocardiography investigation revealed a large circumference effusion. The heart showed intense mobility, preventing the obtainment of ventricle measurements. However, subjective analysis revealed normal dimensions and heart chamber functions.
On the 5 th day of hospitalization, the patient had classical signs of cardiac tamponade (increased jugular disten- Search for LE cells in the blood was negative. PPD was nonreactive. Radiography of the hand and pulses was normal. TSH was 70.14um/L (normal values are between 0.49 -4.67um/L), and free T4 was undetectable, thus diagnosing hypothyroidism. Renewed echocardiography, 12 days after pericardiocentesis, showed a large volume of pericardial effusion. The left ventricle showed decreased relaxation, normal internal dimensions and systolic function, and minimal mitral reflux.
We decided to perform a pericardiotomy and pericardial window (with a biopsy). Anatomopathological analysis showed negative results for granulomatous or other types of diseases. The patient evolved favorably during the postoperative period, without complaints, although thoracic radiography demonstrated pneumomediastinum and obliteration of the left costophrenic sinus. Treatment was with levothyroxine at 75mcg/day and after 3 days, 125mcg/day. She was discharged from the hospital and was followed up as an outpatient.
Discussion
The first known description of pericardial effusion in a hypothyroid patient dates back to 1918 4 . Since then, several publications have reported on the association between hypothyroidism and pericardial effusion, and even other serous effusions 5 . Pericardial effusion is considered the most frequent cardiovascular complication of hypothyroidism, with a prevalence estimated to be between 30% and 80% 1,2 . However, Kabadi and Kumar 6 have questioned this index, associating only cases of severe hypothyroidism with such a high prevalence. The causes related to this accumulation of fluid in the serosa in hypothyroidism remain controversial; some authors believe its cause to be an accumulation of hygroscopic mucopolysaccharides. Parving et al 3 demonstrated as causes, a combination of extravasation of albumin and decreased lymph flow.
Cardiac tamponade as a complication of hypothyroidism is very rare; Jiménez-Nácher et al 7 cite that until 1992 less than 30 cases had been described in the world literature. This low incidence is probably due to the slow accumulation of liquid and to cardiac distensibility 8 . Factors described as provoking cardiac tamponade include infection, spontaneous pericardial hemorrhage, thyroid therapy, and abdominal paracentesis.
Identification of cardiac tamponade in hypothyroidism is therefore difficult and commonly mistaken for cardiac failure due to its symptoms of tachycardia, rise in venous pressure, lower limb edema, and increased cardiac silhouette on radiography.
In our case, diagnosis was based on clinical and echographic findings. Hypothyroidism as the cause of the pericardial effusion and tamponade was diagnosed by an exclusion criterion, because other afflictions (neoplasm, tuberculosis) are the most frequent causes of nontraumatic pericardial effusion. The etiological search of cardiac tamponade should always be performed, even in patients with evident primary hypothyroidism, because this association is a rare one, and other causes of cardiac tamponade require a different or more aggressive treatment 9 . Controversy exists regarding the form of drainage of cardiac tamponade. Some authors suggest an immediate surgical approach (pericardial window) to prevent recurrence; others prefer pericardiocentesis and in case of recurrence, an option for the window 10 . Advantages of the pericardial window are possible tissue biopsy of the pericardium and prevention of recurrences.
Treatment of hypothyroidism is always mandatory following tamponade drainage, because, generally, a residue of the effusate following pericardiocentesis (with a high potential for recurrence) disappears following appropriate therapy over a period varying between 1 month and 1 year, ranging up to 15 months. The most recommended therapeutic scheme is L-thyroxin, at an initial low dose (25mcg/day), increased only progressively, because high doses may propitiate new effusions or decompensation towards tamponade. In the present case, the dose used was of 75mcg/day, increased to 125mcg/day within 3 days, with indefinite continuation. 
